For Human Health
Advanced diagnostic testing for practitioners, clinics, digital health platforms, pharmacies and consumer health brands - with the option of a fully branded, white-label or turnkey solution.
0%
We work with our partners to understand what they're trying to achieve, then help design the complete solution around it - scientific development, test selection, product creation, packaging, manufacturing, fulfilment, digital activation, result reporting, practitioner support, marketing, commercial strategy and implementation.
From a single specialist assay to an entirely new testing brand, we have the scientific capability and commercial experience to make it possible.
Advanced diagnostic testing for practitioners, clinics, digital health platforms, pharmacies and consumer health brands - with the option of a fully branded, white-label or turnkey solution.
Multiplex allergy and intolerance testing for feline, canine and equine patients, built to support referring vets, practices and the wider companion-animal ecosystem.
Our laboratory uses advanced molecular diagnostic and multiplex immunoassay technologies to generate comprehensive sensitisation profiles from a single patient sample. A single small-volume draw can be screened against up to 300 allergens in one process - combining natural allergen extracts with molecular, component-resolved allergens for greater precision, including dedicated screening for drug and chemical sensitisation. Automated processing, standardised workflows and on-strip calibration support consistent, reproducible and scalable testing.
Alongside allergen-specific IgE profiling, our multiplex panels extend to food-specific IgG testing for intolerance, and ELISA-based autoantibody profiling across the major markers associated with autoimmune and connective-tissue disease - giving clinicians a fuller picture from a shared analytical platform.
Science doesn't stand still, and neither do we. We collaborate with universities, CROs, pharmaceutical and biotechnology partners, and other laboratories on assay validation, feasibility studies and new biomarker development - so the tests we offer today aren't the limit of what we can offer tomorrow.